Detalhe da pesquisa
1.
A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee Sera.
J Immunol;
2024 Apr 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38683124
2.
Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial.
Ann Intern Med;
175(2): 226-233, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34807716
3.
Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine.
Am J Transplant;
22(8): 2089-2093, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35266606
4.
Resistance of SARS-CoV-2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020.
Transfusion;
62(1): 37-43, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34662434
5.
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.
Mol Ther;
29(6): 1984-2000, 2021 06 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33578036
6.
Proximity Dependent Biotinylation: Key Enzymes and Adaptation to Proteomics Approaches.
Mol Cell Proteomics;
19(5): 757-773, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32127388
7.
A Versatile Lentiviral Delivery Toolkit for Proximity-dependent Biotinylation in Diverse Cell Types.
Mol Cell Proteomics;
17(11): 2256-2269, 2018 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29991506
8.
Studying Cellular Dynamics Using Proximity-Dependent Biotinylation: Somatic Cell Reprogramming.
Methods Mol Biol;
2718: 23-52, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37665453
9.
Phase I randomized, observer-blinded, placebo-controlled study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B.
Sci Rep;
13(1): 8557, 2023 05 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37236995
10.
RNA-binding proteins that lack canonical RNA-binding domains are rarely sequence-specific.
Sci Rep;
13(1): 5238, 2023 03 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37002329
11.
SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History.
Microbiol Spectr;
10(1): e0226221, 2022 02 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35171006
12.
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses.
Microbiol Spectr;
10(5): e0281122, 2022 10 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36125288
13.
Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings.
Nat Commun;
13(1): 4489, 2022 08 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35927279
14.
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B.
Sci Adv;
8(3): eabj9815, 2022 Jan 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35044832
15.
Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases.
JCI Insight;
7(11)2022 06 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35471956
16.
A simple protein-based surrogate neutralization assay for SARS-CoV-2.
JCI Insight;
5(19)2020 10 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32870820